Abstract

The standard operation of a batch freeze-dryer is protocol driven. All freeze-drying phases (i.e., freezing, primary and secondary drying) are programmed sequentially at fixed time points and within each phase critical process parameters (CPPs) are typically kept constant or linearly interpolated between two setpoints. This way of operating batch freeze-dryers is shown to be time consuming and inefficient. A model-based optimisation and real-time control strategy that includes model output uncertainty could help in accelerating the primary drying phase while controlling the risk of failure of the critical quality attributes (CQAs). In each iteration of the real-time control strategy, a design space is computed to select an optimal set of CPPs. The aim of the control strategy is to avoid product structure loss, which occurs when the sublimation interface temperature () exceeds the the collapse temperature () common during unexpected disturbances, while preventing the choked flow conditions leading to a loss of pressure control. The proposed methodology was experimentally verified when the chamber pressure and shelf fluid system were intentionally subjected to moderate process disturbances. Moreover, the end of the primary drying phase was predicted using both uncertainty analysis and a comparative pressure measurement technique. Both the prediction of and end of primary drying were in agreement with the experimental data. Hence, it was confirmed that the proposed real-time control strategy is capable of mitigating the effect of moderate disturbances during batch freeze-drying.

Highlights

  • Pharmaceutical freeze-drying or lyophilisation is a dehydration process mainly used for stabilizing parenteral therapeutical agents contained in aqueous solutions

  • The optimisation and control strategy was developed on an Amsco-Finn Aqua GT4 freeze-dryer (GEA, Köln, Germany) which was retrofitted with PR-4114 programmable logic controllers (PLC) (PR electronics, Rønde, Denmark) and a Pro-Face AGP3000 (Schneider Electric, Rueil-Malmaison, France) Human-Machine Interface with Modbus TCP/IP communication capabilities

  • New methodologies are being proposed to optimize batch freeze-drying by implementing dynamic settings during primary drying [4]

Read more

Summary

Introduction

Pharmaceutical freeze-drying or lyophilisation is a dehydration process mainly used for stabilizing parenteral therapeutical agents contained in aqueous solutions. When the sublimation rate exceeds this limit it will result in a loss of pressure control of the freeze-dryer During this phenomena, the vapour flow is to high for the dimensions of the limiting channels (vial neck or condenser duct) of the freeze-dryer system resulting in a compression of the gas and a undesirable pressure build up at the ice sublimation interface [4,5]. The loss of pressure control means a loss of control over the heat transfer, which could in turn lead to collapse when surpassing the Tc. The last freeze-drying phase is secondary drying. The last freeze-drying phase is secondary drying It is initiated when all ice is removed by increasing the shelf temperature (Ts) to start desorption of residual bounded water [6,7]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call